{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:48:04Z","timestamp":1793832484963,"version":"4.6.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008062","name":"Fundacion Alicia Koplowitz","doi-asserted-by":"publisher","award":["FCRB_IPB2_2023"],"award-info":[{"award-number":["FCRB_IPB2_2023"]}],"id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016658","name":"Plan Nacional sobre Drogas","doi-asserted-by":"publisher","award":["2022I053"],"award-info":[{"award-number":["2022I053"]}],"id":[{"id":"10.13039\/100016658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/0242"],"award-info":[{"award-number":["PI18\/0242"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["INT19\/00021"],"award-info":[{"award-number":["INT19\/00021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/0391"],"award-info":[{"award-number":["PI21\/0391"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI24\/00279"],"award-info":[{"award-number":["PI24\/00279"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FORT23\/00002_SUGR_G6"],"award-info":[{"award-number":["FORT23\/00002_SUGR_G6"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00330"],"award-info":[{"award-number":["PI21\/00330"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01189"],"award-info":[{"award-number":["PI21\/01189"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI24\/00567"],"award-info":[{"award-number":["PI24\/00567"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00654"],"award-info":[{"award-number":["PI20\/00654"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016145","name":"Ministerio de Sanidad, Consumo y Bienestar Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003136","name":"Edmond J Safra Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["021-SGR-01325"],"award-info":[{"award-number":["021-SGR-01325"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022335","name":"IDIBAPS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SLT006\/17\/00362"],"award-info":[{"award-number":["SLT006\/17\/00362"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["26731"],"award-info":[{"award-number":["26731"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["202232-30-31"],"award-info":[{"award-number":["202232-30-31"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019179","name":"Fundacion La Caixa","doi-asserted-by":"publisher","award":["HR22-00221"],"award-info":[{"award-number":["HR22-00221"]}],"id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopsych.2025.07.006","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T07:57:19Z","timestamp":1752566239000},"page":"189-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Brain Metabolite Levels in the Post-Acute Stage of Anti-NMDA Receptor Encephalitis and Schizophrenia: A Longitudinal Case-Control Study"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-0841","authenticated-orcid":false,"given":"Adriana","family":"Fortea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Ortu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Masias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Guasp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"De la Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Armangue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Borr\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Prades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirea","family":"Rosa-Justicia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy","family":"Mart\u00ednez-Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Compte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Llufriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Castro-Fornieles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Sugranyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2025.07.006_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib2","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1523\/JNEUROSCI.0064-12.2012","article-title":"Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain","volume":"32","author":"Gleichman","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2025.07.006_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: Mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti\u2013N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S1474-4422(22)00299-X","article-title":"Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: A prospective cohort study and comparison with patients with schizophrenia spectrum disorders","volume":"21","author":"Guasp","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: Structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2025.07.006_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108922","article-title":"Glutamate receptors and synaptic plasticity: The impact of Evans and Watkins","volume":"206","author":"Collingridge","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2025.07.006_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pflugers Arch\u2014Eur J Physiol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-5-31","article-title":"In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: Further evidence of synaptic glutamatergic dysfunction","volume":"5","author":"Manto","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.biopsych.2025.07.006_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planagum\u00e0","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2025.07.006_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ana.25829","article-title":"NMDAR antibodies alter dopamine receptors and cause psychotic behavior in mice","volume":"88","author":"Carceles-Cordon","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107088","article-title":"Assessment of long-term psychosocial outcomes in anti-NMDA receptor encephalitis","volume":"108","author":"Blum","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.biopsych.2025.07.006_bib14","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1212\/WNL.0000000000009987","article-title":"Sleep disorders in anti-NMDAR encephalitis","volume":"95","author":"Ari\u00f1o","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2025.07.006_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tins.2016.02.006","article-title":"NMDA receptor internalization by autoantibodies: A reversible mechanism underlying psychosis?","volume":"39","author":"Masdeu","year":"2016","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2025.07.006_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41582-023-00904-0","article-title":"Schizophrenia: From neurochemistry to circuits, symptoms and treatments","volume":"20","author":"Howes","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib17","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2025.07.006_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.schres.2019.03.010","article-title":"NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms","volume":"217","author":"Snyder","year":"2020","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2025.07.006_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","article-title":"Mapping genomic loci implicates genes and synaptic biology in schizophrenia","volume":"604","author":"Trubetskoy","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2025.07.006_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nic.2008.08.002","article-title":"Proton magnetic resonance spectroscopy in multiple sclerosis","volume":"19","author":"Sajja","year":"2009","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.biopsych.2025.07.006_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamapsychiatry.2018.3637","article-title":"Assessing brain metabolism with 7-T proton magnetic resonance spectroscopy in patients with first-episode psychosis","volume":"76","author":"Wang","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib24","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s10067-023-06680-y","article-title":"Persistent neuroinflammation of the right insular cortex in children with juvenile idiopathic arthritis: A proton MRS study","volume":"42","author":"Han","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib25","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1038\/s41598-018-23155-2","article-title":"Dynamic metabolic patterns tracking neurodegeneration and gliosis following 26S proteasome dysfunction in mouse forebrain neurons","volume":"8","author":"Geiszler","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2025.07.006_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101503","article-title":"Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer\u2019s disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies","volume":"72","author":"Song","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.biopsych.2025.07.006_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118225","article-title":"An in-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue","volume":"238","author":"Tackley","year":"2021","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2025.07.006_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fpsyt.2018.00438","article-title":"Putative astroglial dysfunction in schizophrenia: A meta-analysis of 1H-MRS studies of medial prefrontal myo-inositol","volume":"9","author":"Das","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2020.10.001","article-title":"Proton magnetic resonance spectroscopy of N-acetyl aspartate in chronic schizophrenia, first episode of psychosis and high-risk of psychosis: A systematic review and meta-analysis","volume":"119","author":"Whitehurst","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2025.07.006_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12888-015-0552-4","article-title":"Hypoglutamatergic state is associated with reduced cerebral glucose metabolism in anti-NMDA receptor encephalitis: A case report","volume":"15","author":"Endres","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5692\/clinicalneurol.48.196","article-title":"Subacute encephalitis associated with anti-glutamate receptor antibodies: Serial studies of MRI, 1H-MRS and SPECT","volume":"48","author":"Yamamoto","year":"2008","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.biopsych.2025.07.006_bib32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.22167","article-title":"Reduced N-acetylaspartate in the basal ganglia of a patient with anti-NMDA receptor encephalitis","volume":"24","author":"Kataoka","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2025.07.006_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1971400915609333","article-title":"Magnetic resonance imaging and magnetic resonance spectroscopy in a young male patient with anti-N-methyl-D-aspartate receptor encephalitis and uncommon cerebellar involvement: A case report with review of the literature","volume":"29","author":"Splendiani","year":"2016","journal-title":"Neuroradiol J"},{"key":"10.1016\/j.biopsych.2025.07.006_bib34","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/s41380-023-01969-5","article-title":"Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: A 7-Tesla MRS study","volume":"28","author":"Wang","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib35","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s41380-023-01991-7","article-title":"Variability and magnitude of brain glutamate levels in schizophrenia: A meta and mega-analysis","volume":"28","author":"Merritt","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/jamapsychiatry.2021.0380","article-title":"Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: A mega-analysis of individual participant-level data","volume":"78","author":"Merritt","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/00048674241254216","article-title":"Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders","volume":"58","author":"Lopes","year":"2024","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.biopsych.2021.06.008","article-title":"Medial prefrontal cortex glutamate is reduced in schizophrenia and moderated by measurement quality: A meta-analysis of proton magnetic resonance spectroscopy studies","volume":"90","author":"Smucny","year":"2021","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/schbul\/sbv118","article-title":"Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: A proton magnetic resonance spectroscopy study with implications for glial dysfunction","volume":"42","author":"Plitman","year":"2016","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2025.07.006_bib40","series-title":"WAIS-IV Administration and Scoring Manual","author":"Wechsler","year":"2008"},{"key":"10.1016\/j.biopsych.2025.07.006_bib41","series-title":"Wechsler Intelligence Scale for Children","author":"Wechsler","year":"2014"},{"key":"10.1016\/j.biopsych.2025.07.006_bib42","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbu001","article-title":"Dose equivalents for second-generation antipsychotics: The minimum effective dose method","volume":"40","author":"Leucht","year":"2014","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2025.07.006_bib43","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.biopsych.2025.07.006_bib44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/jamapsychiatry.2022.1513","article-title":"Assessment of noninvasive brain stimulation interventions for negative symptoms of schizophrenia: A systematic review and network meta-analysis","volume":"79","author":"Tseng","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1017\/S0033291717001283","article-title":"Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium","volume":"48","author":"Walton","year":"2018","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2025.07.006_bib46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2025.07.006_bib47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/nbm.891","article-title":"Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts","volume":"17","author":"Kreis","year":"2004","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2025.07.006_bib48","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2025.07.006_bib49","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2025.07.006_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113166","article-title":"Human NMDAR autoantibodies disrupt excitatory-inhibitory balance, leading to hippocampal network hypersynchrony","volume":"42","author":"Ceanga","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.biopsych.2025.07.006_bib51","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1523\/JNEUROSCI.16-23-07496.1996","article-title":"Direct measurement of AMPA receptor desensitization induced by glutamatergic synaptic transmission","volume":"16","author":"Otis","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2025.07.006_bib52","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0896-6273(92)90250-H","article-title":"Activation and desensitization of glutamate-activated channels mediating fast excitatory synaptic currents in the visual cortex","volume":"9","author":"Hestrin","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2025.07.006_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12868-023-00823-2","article-title":"Typical metabolic pattern of 18F-FDG PET in anti-NMDAR encephalitis in the acute and subacute phases and its correlation with T2 FLAIR-MRI features","volume":"24","author":"Yuan","year":"2023","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.biopsych.2025.07.006_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib55","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2025.07.006_bib56","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.biopsych.2015.02.024","article-title":"Structural hippocampal damage following anti-N-methyl-D-aspartate receptor encephalitis","volume":"79","author":"Finke","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib57","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/jnnp-2017-316822","article-title":"Superficial white matter damage in anti-NMDA receptor encephalitis","volume":"89","author":"Phillips","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib58","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S2215-0366(17)30330-9","article-title":"Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: An observational study","volume":"4","author":"Peer","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41386-021-01132-0","article-title":"The role of prefrontal cortex in cognitive control and executive function","volume":"47","author":"Friedman","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2025.07.006_bib60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2025.07.006_bib61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41386-021-01089-0","article-title":"Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia","volume":"47","author":"Smucny","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2025.07.006_bib62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41398-021-01385-9","article-title":"Glutamate and microglia activation as a driver of dendritic apoptosis: A core pathophysiological mechanism to understand schizophrenia","volume":"11","author":"Parellada","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S2215-0366(19)30302-5","article-title":"Glial cells in schizophrenia: A unified hypothesis","volume":"7","author":"Dietz","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2025.07.006_bib64","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: Clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2025.07.006_bib65","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamaneurol.2016.0232","article-title":"Association of progressive cerebellar atrophy with long-term outcome in patients with anti-N-methyl-d-aspartate receptor encephalitis","volume":"73","author":"Iizuka","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.biopsych.2025.07.006_bib66","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/nbm.3364","article-title":"Single-voxel (1)H spectroscopy in the human hippocampus at 3 T using the LASER sequence: Characterization of neurochemical profile and reproducibility","volume":"28","author":"Alla\u00efli","year":"2015","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2025.07.006_bib67","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/brain\/awae410","article-title":"Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis","volume":"148","author":"Maudes","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2025.07.006_bib68","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ana.26241","article-title":"Long-term cognitive outcome in anti-N-methyl-D-aspartate receptor encephalitis","volume":"90","author":"Heine","year":"2021","journal-title":"Ann Neurol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322325013162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322325013162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:23:39Z","timestamp":1782293019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322325013162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0006322325013162"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2025.07.006","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain Metabolite Levels in the Post-Acute Stage of Anti-NMDA Receptor Encephalitis and Schizophrenia: A Longitudinal Case-Control Study","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2025.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}